Women’s Health
-
Prenatal PFAS exposure linked to long-term maternal beta-cell dysfunction, new NIH study reveals
NIH-funded research shows prenatal PFAS exposure increases maternal beta-cell dysfunction risk by 15-20% a decade postpartum, with epigenetic changes as a key mechanism. Emerging evidence…
-
Precision nutrition for breast cancer survivors: how genetic testing could personalize soy intake
Emerging research shows genetic factors influence soy’s effects on hormonal health, enabling personalized dietary recommendations for breast cancer survivors undergoing endocrine therapy. New studies reveal…
-
Prenatal PFAS exposure linked to long-term maternal metabolic dysfunction, new studies reveal
Emerging research shows prenatal PFAS exposure significantly increases risks of gestational diabetes and long-term metabolic disorders through beta cell disruption. Groundbreaking 2024 studies demonstrate PFAS…
-
Prenatal PFAS exposure linked to lifelong maternal diabetes risk and epigenetic changes in offspring
New research reveals prenatal PFAS exposure significantly increases maternal diabetes risk and may cause epigenetic changes affecting offspring metabolic health. Groundbreaking studies show PFAS chemicals…
-
Prenatal PFAS exposure linked to long-term maternal metabolic risks, new studies reveal
Recent research shows prenatal PFAS exposure significantly increases risks of gestational diabetes and postpartum metabolic disorders, with socioeconomic disparities in exposure levels. Emerging evidence demonstrates…
-
Prenatal PFAS exposure linked to long-term maternal metabolic dysfunction, new studies reveal
Emerging research shows prenatal PFAS exposure significantly impacts maternal metabolic health, increasing risks of gestational diabetes and long-term beta cell dysfunction. Groundbreaking studies demonstrate that…
-
Navigating dietary choices during endocrine therapy: evidence-based recommendations for women
Expert-backed dietary strategies to manage endocrine therapy side effects like arthralgia and weight gain, featuring omega-3s, vitamin D, and phytoestrogen research. New research reveals how…
-
Prenatal PFAS exposure linked to long-term maternal metabolic dysfunction, new studies reveal
Recent research shows prenatal PFAS exposure significantly increases risks of gestational diabetes and insulin resistance, with new data revealing widespread contamination in pregnant women. Emerging…
-
Prenatal PFAS exposure linked to long-term maternal metabolic dysfunction, new studies reveal
Recent research shows prenatal PFAS exposure significantly impacts maternal metabolic health, increasing diabetes risk and impairing beta-cell function decades after pregnancy. Emerging evidence demonstrates that…
-
Prenatal PFAS exposure linked to maternal beta cell dysfunction and long-term metabolic risks
Recent studies reveal that prenatal PFAS exposure is associated with impaired maternal beta cell function, increasing risks for gestational diabetes and metabolic disorders. New research…